Raymond James Upgrades CME Group (CME)

Fintel reports that on March 10, 2025, Raymond James upgraded their outlook for CME Group (NasdaqGS:CME) from Market Perform to Outperform.

Analyst Price Forecast Suggests 0.48% Upside

As of March 4, 2025, the average one-year price target for CME Group is $263.60/share. The forecasts range from a low of $202.00 to a high of $304.50. The average price target represents an increase of 0.48% from its latest reported closing price of $262.35 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for CME Group is 5,569MM, a decrease of 9.01%. The projected annual non-GAAP EPS is 9.10.

What is the Fund Sentiment?

There are 2,461 funds or institutions reporting positions in CME Group. This is an increase of 98 owner(s) or 4.15% in the last quarter. Average portfolio weight of all funds dedicated to CME is 0.48%, an increase of 15.81%. Total shares owned by institutions increased in the last three months by 2.73% to 379,942K shares. The put/call ratio of CME is 0.53, indicating a bullish outlook.

What are Other Shareholders Doing?

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 11,290K shares representing 3.13% ownership of the company. In its prior filing, the firm reported owning 11,418K shares , representing a decrease of 1.13%. The firm increased its portfolio allocation in CME by 2.56% over the last quarter.

Capital World Investors holds 11,213K shares representing 3.11% ownership of the company. In its prior filing, the firm reported owning 12,131K shares , representing a decrease of 8.19%. The firm decreased its portfolio allocation in CME by 4.74% over the last quarter.

Jpmorgan Chase holds 10,793K shares representing 3.00% ownership of the company. In its prior filing, the firm reported owning 10,456K shares , representing an increase of 3.12%. The firm increased its portfolio allocation in CME by 4.95% over the last quarter.

VFINX - Vanguard 500 Index Fund Investor Shares holds 9,754K shares representing 2.71% ownership of the company. In its prior filing, the firm reported owning 9,431K shares , representing an increase of 3.31%. The firm increased its portfolio allocation in CME by 2.98% over the last quarter.

Geode Capital Management holds 8,389K shares representing 2.33% ownership of the company. In its prior filing, the firm reported owning 8,285K shares , representing an increase of 1.25%. The firm increased its portfolio allocation in CME by 2.13% over the last quarter.

CME Group Background Information
(This description is provided by the company.)

As the world's leading and most diverse derivatives marketplace, CME Group enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equityindexes, foreign exchange, energy, agricultural products and metals.The company offers futures and options on futures trading through the CMEGlobex® platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. With a range of pre- and post-trade products and services underpinning the entire lifecycle of a trade, CME Group also offers optimization and reconciliation services through TriOptima, and trade processing services through Traiana.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.